Biomarkers of liver injury during transplantation in an era of machine perfusion
Affiliation
University of Birmingham; University Hospitals Birmingham NHS Foundation Trust; The Royal Marsden Hospital NHS Foundation TrustPublication date
2020-02-25
Metadata
Show full item recordAbstract
Liver ischaemia-reperfusion injury (IRI) is an intrinsic part of the transplantation process and damages the parenchymal cells of the liver including hepatocytes, endothelial cells and cholangiocytes. Many biomarkers of IRI have been described over the past two decades that have attempted to quantify the extent of IRI involving different hepatic cellular compartments, with the aim to allow clinicians to predict the suitability of donor livers for transplantation. The advent of machine perfusion has added an additional layer of complexity to this field and has forced researchers to re-evaluate the utility of IRI biomarkers in different machine preservation techniques. In this review, we summarise the current understanding of liver IRI biomarkers and discuss them in the context of machine perfusion.Citation
Bhogal RH, Mirza DF, Afford SC, Mergental H. Biomarkers of Liver Injury during Transplantation in an Era of Machine Perfusion. Int J Mol Sci. 2020 Feb 25;21(5):1578. doi: 10.3390/ijms21051578.Type
ArticleAdditional Links
https://www.mdpi.com/journal/ijmsPMID
32106626Publisher
MDPIae974a485f413a2113503eed53cd6c53
10.3390/ijms21051578